 |
The Journal of Neuroscience, January 18, 2006, 26(3):981-990; doi:10.1523/JNEUROSCI.4617-05.2006
Previous Article | Next Article 
Neurobiology of Disease
Human Immunodeficiency Virus (HIV)-Induced Neurotoxicity: Roles for the NMDA Receptor Subtypes
Lauren A. O'Donnell,1
Arpita Agrawal,1
Kelly L. Jordan-Sciutto,2
Marc A. Dichter,1
David R. Lynch,1 and
Dennis L. Kolson1
1Department of Neurology, School of Medicine, and 2Department of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Neuronal damage in human immunodeficiency virus type 1 (HIV-1) infection in the brain is thought to occur at least in part through NMDA receptor (NMDAR) excitation initiated by soluble neurotoxins from HIV-infected brain macrophages. Furthermore, brain regions enriched in NMDAR-2A (NR2A) and NMDAR-2B (NR2B) subunits, such as the hippocampus, are particularly vulnerable. Using cultured rat hippocampal cells and HIV-1-infected human monocyte-derived macrophages (HIV/MDM), we examined the role of NR2A and NR2B in HIV/MDM-induced hippocampal neuronal death. We used the primary HIV-1 strain Jago derived from the CSF of an individual with HIV-associated dementia and that robustly replicates in MDM. We found the following: (1) hippocampal neuronal susceptibility to HIV/MDM excitotoxins varies according to the developmental expression patterns of NR2A and NR2B; (2) NMDAR activation by HIV/MDM results in neuronal calpain activation, which results in neuronal death; and (3) selective antagonists of homomeric NR2B/NR2B- and heteromeric NR2A/NR2B-containing NMDARs, as well as an inhibitor of calpain activity, afford neuroprotection against HIV/MDM. These studies establish a clear link between macrophage HIV infection, neuronal NR2A and NR2B activation, and calpain-mediated hippocampal neuronal death. They further suggest a dominant role for NR2A and NR2B in determining neuronal susceptibility in HIV-infected brain. Antagonists of NR2A and NR2B subunits as well as inhibitors of calpain activation offer attractive neuroprotective approaches against HIV in both developing and mature brain.
Key words: HIV-1; NMDA receptor; calpain; hippocampus; virus; neurotoxicity; macrophage
Received Aug 25, 2005;
revised December 1, 2005;
accepted December 6, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
V. R. Rao, A. R. Sas, E. A. Eugenin, N. B. Siddappa, H. Bimonte-Nelson, J. W. Berman, U. Ranga, W. R. Tyor, and V. R. Prasad
HIV-1 Clade-Specific Differences in the Induction of Neuropathogenesis
J. Neurosci.,
October 1, 2008;
28(40):
10010 - 10016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, T. P. Wong, M. Aarts, A. Rooyakkers, L. Liu, T. W. Lai, D. C. Wu, J. Lu, M. Tymianski, A. M. Craig, et al.
NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo
J. Neurosci.,
March 14, 2007;
27(11):
2846 - 2857.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|